7
Views
6
CrossRef citations to date
0
Altmetric
Original article

Albumin and Immunoglobulin Turnover in Patients with Chronic Active Liver Disease Treated with Prednisone

, , &
Pages 623-630 | Received 05 Jun 1972, Accepted 08 Jul 1972, Published online: 23 Feb 2010
 

Abstract

Albumin and IgG turnover were studied in 12 patients with chronic active liver disease before, and at a variable time interval during, prolonged prednisone treatment. Before treatment, serum albumin concentration was subnormal in 9 and albumin synthetic rate reduced in 6 and low normal in 4. Serum IgG concentration and IgG synthetic rate were increased in all patients. During treatment 8 patients improved or were unchanged, and 4 deteriorated. In the former group the mean serum albumin concentration and albumin synthetic rate increased significantly, in the latter both values decreased. Serum IgG concentration and IgG synthetic rate decreased in all but one during treatment. The changes were more pronounced in the former than in the latter group. The changes in serum concentrations and synthetic rates of albumin and IgG were significantly negatively correlated, both in the whole material, and especially in patients who improved. The synthetic rates of albumin and IgG were not correlated before or during prednisone administration. Corticosteroids probably inhibit antibody production and stimulate albumin synthesis in chronic liver disease by two separate mechanisms.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.